EJNMMI Radiopharmacy and Chemistry (Oct 2023)
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
- Jean DaSilva,
- Clemens Decristoforo,
- Robert H. Mach,
- Guy Bormans,
- Giuseppe Carlucci,
- Mohammed Al-Qahtani,
- Adriano Duatti,
- Antony D. Gee,
- Wiktor Szymanski,
- Sietske Rubow,
- Jeroen Hendrikx,
- Xing Yang,
- Hongmei Jia,
- Junbo Zhang,
- Peter Caravan,
- Hua Yang,
- Jan Rijn Zeevaart,
- Miguel Avila Rodriquez,
- Ralph Santos Oliveira,
- Marcela Zubillaga,
- Tamer Sakr,
- Sarah Spreckelmeyer
Affiliations
- Jean DaSilva
- University of Montreal
- Clemens Decristoforo
- Medical University Innsbruck
- Robert H. Mach
- University of Pennsylvania
- Guy Bormans
- University of Leuven
- Giuseppe Carlucci
- UCLA
- Mohammed Al-Qahtani
- King Faisal Specialist Hospital and Research Center
- Adriano Duatti
- University of Ferrara
- Antony D. Gee
- King’s College
- Wiktor Szymanski
- University of Groningen
- Sietske Rubow
- Stellenbosch University
- Jeroen Hendrikx
- NKI
- Xing Yang
- Peking University First Hospital
- Hongmei Jia
- Beijing Normal University
- Junbo Zhang
- Beijing Normal University
- Peter Caravan
- Massuchusetts General Hospital, Harvard University
- Hua Yang
- TRIUMF
- Jan Rijn Zeevaart
- Necsa
- Miguel Avila Rodriquez
- Universidad Nacional Autonoma de Mexico (UNAM)
- Ralph Santos Oliveira
- Brazilian Association of Radiopharmacy Brazil, Brazilian Nuclear Energy Commission - Nuclear Engineering Institute, State University of Rio de Janeiro
- Marcela Zubillaga
- University of Buenos Aires
- Tamer Sakr
- Egyptian Atomic Energy Authority
- Sarah Spreckelmeyer
- Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health
- DOI
- https://doi.org/10.1186/s41181-023-00218-y
- Journal volume & issue
-
Vol. 8,
no. 1
pp. 1 – 19
Abstract
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main body This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Keywords
- Highlight articles
- Radiochemistry
- Radiopharmacy
- Radiopharmaceutical sciences
- Nuclear medicine
- Trends in radiopharmaceutical sciences
